Effect of hydrocortisone versus methylprednisolone on clinical outcomes in oncology patients with septic shock.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Corticosteroids are used as adjunctive treatment of critical illness-related corticosteroid insufficiency in patients with septic shock. This study aims to compare the impact of hydrocortisone versus methylprednisolone on duration of septic shock in critically ill oncology patients.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J Oncol Pharm Pract

Title: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Publisher: SAGE Publications

ISSN (Electronic): 1477-092X

ISSN (Print): 1078-1552

Publication date (Electronic): Jan 2021

Volume: 27

Issue: 1

Affiliations

[1 ] Division of Pharmacy, University of Texas MD Anderson Cancer Center, Houston, USA.

[2 ] Division of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, USA.

Article

DOI: 10.1177/1078155220910788

PubMed ID: 32686618

SO-VID: ee51a4fd-6b57-4124-a468-073ee5a1c716

History

Keywords: Septic shock,methylprednisolone,hydrocortisone,malignancy

Data availability:

Keywords: Septic shock, methylprednisolone, hydrocortisone, malignancy

Comments

Comment on this article

Cited by 1

Effect of methylprednisolone vs hydrocortisone on 30-day mortality in critically ill adults with septic shock: an analysis of the MIMIC-IV database
Authors: Jun Xu, Hongliu Cai, Xia Zheng

See all cited by